Here are the latest quarterly results of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA financial fact sheet and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19* |
3
Jun-19* |
3
Sep-19* |
3
Dec-19* |
3
Mar-20* |
3
Jun-20* |
3
Sep-20* |
3
Dec-20* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,270 | 9,489 | 12,409 | 12,091 | 12,068 | 13,413 | 14,571 | 13,143 | |
Other income | Rs m | 34 | 33 | 4 | 4 | 9 | 3 | 32 | 25 | |
Turnover | Rs m | 9,303 | 9,522 | 12,412 | 12,095 | 12,077 | 13,416 | 14,603 | 13,169 | |
Expenses | Rs m | 7,489 | 7,240 | 8,954 | 8,841 | 8,793 | 9,340 | 10,137 | 9,492 | |
Gross profit | Rs m | 1,783 | 1,964 | 3,455 | 3,251 | 3,167 | 4,074 | 4,434 | 3,651 | |
Depreciation | Rs m | 300 | 354 | 360 | 418 | 441 | 415 | 438 | 470 | |
Interest | Rs m | 51 | 50 | 71 | 74 | 77 | 67 | 45 | 23 | |
Profit before tax | Rs m | 1,467 | 1,593 | 3,029 | 2,763 | 2,657 | 3,595 | 3,984 | 3,183 | |
Tax | Rs m | 149 | 360 | 525 | 486 | 621 | 668 | 730 | 591 | |
Profit after tax | Rs m | 1,318 | 1,233 | 2,504 | 2,277 | 2,035 | 2,927 | 3,254 | 2,592 | |
Gross profit margin | % | 19.2 | 20.7 | 27.8 | 26.9 | 26.2 | 30.4 | 30.4 | 27.8 | |
Effective tax rate | % | 10.2 | 22.6 | 17.3 | 17.6 | 23.4 | 18.6 | 18.3 | 18.6 | |
Net profit margin | % | 14.2 | 13.0 | 20.2 | 18.8 | 16.9 | 21.8 | 22.3 | 19.7 | |
Diluted EPS | Rs | 7.0 | 6.5 | 13.3 | 12.1 | 10.8 | 15.5 | 17.3 | 13.7 | |
Diluted EPS (TTM) | Rs | 31.4 | 33.2 | 35.9 | 38.9 | 42.7 | 51.7 | 55.7 | 57.3 | |
![]() |
Read: ALEMBIC PHARMA 3QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: LUPIN INDOCO REMEDIES CIPLA PANACEA BIOTECH GSK PHARMA
Compare ALEMBIC PHARMA With: LUPIN INDOCO REMEDIES CIPLA PANACEA BIOTECH GSK PHARMA
Compare ALEMBIC PHARMA With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.
For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More